Dallah Healthcare Co. (4004.SR) Financials
4004.SR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 6.2 billion | 2.8 billion |
| 2023-09-30 | 6.1 billion | 2.7 billion |
| 2023-06-30 | 6.1 billion | 2.7 billion |
| 2023-03-31 | 6.1 billion | 2.7 billion |
4004.SR Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 118.6 million | ? |
| 2023-09-30 | 61.0 million | ? |
| 2023-06-30 | 114.9 million | ? |
| 2023-03-31 | 34.6 million | ? |
4004.SR Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 113.7 million |
| 2023-09-30 | 98.9 million |
| 2023-06-30 | 53.0 million |
| 2023-03-31 | 94.7 million |
4004.SR Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 78.7 million |
| 2023-09-30 | - | - | 51.2 million |
| 2023-06-30 | - | - | 42.4 million |
| 2023-03-31 | - | - | 42.6 million |
4004.SR Shares Outstanding
4004.SR Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 151.3 million | - | -262.4 million | - |
| 2023-09-30 | 72.3 million | - | 152.2 million | - |
| 2023-06-30 | 32.0 million | - | 142.8 million | - |
| 2023-03-31 | 41.0 million | - | 130.3 million | - |
4004.SR Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 806.0 million | 510.1 million |
| 2023-09-30 | 749.8 million | 469.0 million |
| 2023-06-30 | 670.4 million | 435.3 million |
| 2023-03-31 | 716.6 million | 449.8 million |
4004.SR
Price: SAR164.60
Dividend Yield: 0.01%
Forward Dividend Yield: 1.20%
Payout Ratio: 54.05%
Dividend Per Share: 2.00 SAR
Earnings Per Share: 3.70 SAR
P/E Ratio: 49.50
Exchange: SAU
Sector: Healthcare
Industry: Medical Care Facilities
Market Capitalization: 16.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 12
DGR3: 30.00%
DGR5: 30.00%